doi: 10.2147/DDDT.S556231, Summary Keywords fibrosis, glucagon-like peptide-1 receptor agonists, inflammation, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease Citation Lu X and Yang L (2026) Glucagon-like peptide-1 and dual/triple receptor agonists in the treatment of metabolic dysfunction-associated steatotic liver disease: advances in mechanistic research
In the STEP 3 clinical trials, 611 adults with overweight or obesity without diabetes were enrolled to receive intensive behavioral therapy (IBT) combined with an initial low-calorie diet
Mobility, stability, and compensation patterns A structured evaluation of how your body moves and compensates
For these reasons, adequate vitamin B 12 intake during pregnancy (RDA=2.6 g/day) is important
and glucagon-receptor activity may influence energy expenditure and liver-related metabolism